New Products

MORRISTOWN, N.J. — Bayer HealthCare's Consumer Care Division on Tuesday introduced Bayer Migraine Formula, an over-the-counter medication designed to relieve migraine pain and accompanying symptoms like nausea, phonophobia (sound sensitivity) and photophobia (light sensitivity) through a formulation of aspirin, acetaminophen and caffeine.

SILVER SPRING, Md. — According to a Food and Drug Administration post Friday, the FDA's Nonprescription Drugs Advisory Committee will be meeting Nov. 9 regarding the partial switch application from prescription to over the counter of Oxytrol (oxybutynin transdermal system) submitted by MSD Consumer. The proposed OTC product would be called Oxytrol for Women and would be indicated for the treatment of overactive bladder in women.

The prescription form of Oxytrol is licensed by Watson Pharma.

LOS ANGELES — Beauty brand Wet 'n Wild took 2012 by storm by signing international pop culture icon Fergie as its first ever global beauty ambassador and has now announced the launch of the first line from the collaboration. Enter Fergie by Wet 'n Wild nail color collection.

TOLEDO, Ohio — Mark Feldstein and Associates has introduced its new holiday musical clocks.

MFA said its North Pole cuckoo clock depicts Christmas elves helping Santa Claus getting ready for the "big day" in his workshop at the North Pole. At each hour, an elf comes out of the workshop accompanied by one of twelve Christmas carols. The clock features a swinging pendulum which can be removed for mantel or tabletop display. In addition to the North pole cuckoo clock, MFA also is offering the following 8-in. holiday musical clocks:

SILVER SPRING, Md. — The Food and Drug Administration has approved a new formulation of a cancer drug made by Novartis for a type of brain tumor in children, the agency said.

The FDA announced the approval of Afinitor Disperz (everolimus) tablets for oral suspension to treat a rare brain tumor called subependymal giant-cell astrocytoma, or SEGA. The agency said Afinitor Disperz, a new dosage form of the drug Afinitor, is the first pediatric-specific dosage form for a pediatric tumor to receive FDA approval.

PARSIPPANY, N.J. — The Food and Drug Administration has approved a generic antidepressant made by Wockhardt, the Indian drug maker said Tuesday.

Wockhardt announced the FDA approval of its bupropion hydrochloride extended-release tablets in the 100 mg, 150 mg and 200 mg strengths.

The drug is a generic version of GlaxoSmithKline's Wellbutrin SR, various versions of which have a market of about $268 million, according to IMS Health.

INDIANPOLIS — Lilly Diabetes announced that it has launched a new mobile application designed for caregivers and healthcare providers who support people with Type 1 diabetes.

The Lilly Glucagon mobile app is an interactive tool designed to teach caregivers how to use severe hypoglycemia treatment Glucagon (1-mg) for injection through simulated practice, thus helping caregivers better understand Glucagon's role in diabetes management. The Lilly Glucagon mobile app includes:

• Information about severe hypoglycemia and Glucagon;

HORSHAM, Pa. — Symphony Health Solutions has expanded its senior leadership team.

The company — which is owned by Palo Alto, Calif.-based strategic equity firm Symphony Technology Group — said former SunGuard Higher Education CFO John Milana has been appointed CFO of the company;  Jonathan Rosan, who had served as general counsel for interactive marketing agency Rosetta, has been named general counsel; and software engineering veteran Nigel Pratt has been named chief technology officer.